About ▼ Careers Internship MedBlog Contact us

Bayer Announces that Loxo Oncology, Inc., Initiates Rolling NDA Submission for Larotrectinib for the Treatment of TRK Fusion Cancers

Completion of NDA submission expected in early 2018

Latest Press Release on Cancer News

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

SAN DIEGO and WUHAN, China , April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled " Narazaciclib, a novel multikinase inhibitor...

SynOx Therapeutics announces $75m Series B round to fund Phase 3 trial of potential best-in-class treatment for TGCT

Financing co-led by Forbion, HealthCap and new investor Bioqube Ventures Funds will be used for pivotal trial of potential best-in-class, next-generation treatment for Tenosynovia...

The Melanoma Research Foundation to host the New England Miles for Melanoma 5K

The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients...

GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer

SHANGHAI , April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US...

Cancer Patients Can't Afford Pet Food and Vet Care, CancerCare Survey Finds

Some Cancer Patients Would Rather Stop Treatment Than Give Up Their Pets NEW YORK , April 18, 2024 /PRNewswire/ -- The companionship and support of a pet can be a lifeline for...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close